Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome

PaperCitations, authors & open-access status

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 63 citations, 2023 year and gold oa status.

63
Citations
2023
Year
gold
OA Status

Related on ScholarIQ

Alla Mitrofanova
Author
Renal Diseases and Glomerulopathies
Topic
Renal Diseases and Glomerulopathies
Topic
Diabetes Treatment and Management
Topic
Pancreatic function and diabetes
Topic
470M+ articles · free account